Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    Open Studies | "Polymyalgia Rheumatica"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Polymyalgia Rheumatica"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
Condition: Polymyalgia Rheumatica
Interventions: Drug: Tocilizumab;   Drug: Placebo
2 Not yet recruiting Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone /Prednisone placebo
3 Not yet recruiting Polymyalgia Rheumatica and Giant Cell Arteritis
Conditions: Polymyalgia Rheumatica;   Giant Cell Arteritis
Intervention: Other: 18F-FDG PET/CT
4 Recruiting Biomarkers in Giant Cells Arteritis
Condition: Giant Cells Arteritis
Interventions: Behavioral: Clinical evaluation;   Other: Paraclinical evaluation;   Device: Imaging;   Other: Ophthalmologic examination;   Biological: Dosage of biomarkers
5 Recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
6 Recruiting Delayed Release Prednisone in PMR
Condition: Polymyalgia Rheumatica
Interventions: Drug: Delayed-Release (DR) Prednisone;   Drug: Immediate Release (IR) Prednisone
7 Recruiting Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease
Condition: Horton's Disease
Intervention: Biological: Blood samples
8 Not yet recruiting Giant Cell Arteritis and Anakinra Trial
Condition: Giant Cell Arteritis
Interventions: Drug: PLACEBO;   Drug: ANAKINRA
9 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
10 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
11 Recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
12 Recruiting Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease
Condition: Horton Disease
Interventions: Radiation: Vascular tomodensitometry;   Other: Magnetic resonance angiography;   Other: Vascular ultrasonography;   Other: Retinal angiography;   Other: Retinal optical coherence tomography
13 Not yet recruiting Ustekinumab for the Treatment of Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Temporal Arteritis;   Horton's Disease
Interventions: Drug: Ustekinumab;   Drug: Prednisone
14 Recruiting Validation of a Diagnostic Algorithm of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Other: color Doppler ultrasound and TAB in case of CDU negative
15 Recruiting Improving the Diagnosis and Prognostication of GCA Through the Novel Use of PET Scan and Immune Biomarkers
Condition: Giant Cell Arteritis
Intervention:
16 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
17 Not yet recruiting Aetiology of TemporaL Arteritis Study
Condition: Temporal Arteritis
Intervention:
18 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
19 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
20 Recruiting VCRC Tissue Repository
Conditions: Aortitis;   Cutaneous Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis;   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Henoch-Schonlein Purpura;   IgA Vasculitis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu Arteritis;   Churg-Strauss Syndrome
Intervention:

Study has passed its completion date and status has not been verified in more than two years.